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Silica 0.004 0.230 0.023 0.014 0.189 0.000 0.005 0.001
Cadmium 0.000 0.000 0.005 0.003 0.003 0.000 0.001 0.000
Nickel 0.000 0.020 0.017 0.004 0.000 0.000 0.000 0.000
Arsenic 0.001 0.001 0.004 0.001 0.001 0.000 0.000 0.000
Chro-
mium 0.000 0.003 0.021 0.004 0.002 0.000 0.004 0.002
Diesel 
Fumes 0.006 0.220 0.011 0.034 0.058 0.005 0.134 0.009
Beryllium 0.000 0.001 0.002 0.001 0.000 0.000 0.000 0.000
Asbestos 0.012 0.102 0.006 0.017 0.052 0.003 0.007 0.003
Table 3: Proportion of workers exposed to lung carcinogens, by industry 
based on the CAREX estimates (FIOH, 1998).
Conclusion: The incidence of lung cancer due to occupational expo-
sure is low in our country and as it is the case for other populations, 
there is more lung cancer due to occupational exposure among male 
compared to female. 
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Background: The aim of this study is to compare the clinical outcomes 
of patients diagnosed with small cell cancer of unknown primary 
(CUP) origin to those diagnosed with metastatic small cell cancer of 
known origin. 
Methods: All persons diagnosed with cancer in New South Wales, 
Australia, from 1980 to 2004 were studied using a population based 
cancer registry. Patients classiﬁed as small cell CUP were documented 
and survival outcome compared to those with initial small cell meta-
static presentations with a known primary site, for the same period. 
This register collects degrees of cancer spread at diagnosis as localised, 
regional and metastatic but does not use a clinical staging system. 
Results: There were 65,239 histologically or cytologically conﬁrmed 
metastatic cancers identiﬁed at initial presentation of which 14,502 
were CUP. Further classiﬁcation into histological subsets showed that 
3,713 (5.7%) of metastatic presentation were small cell cancer. Of 
those diagnosed with small cell histology, 516 (14%) were CUP and 
the rest were classiﬁed as advanced small cell with a known primary 
site. CUP had a signiﬁcantly higher proportion of females and older 
individuals compared to metastatic cancer of known primary site. 
Logistic regression analysis controlling for age and sex revealed that 
small cell CUP had signiﬁcantly better survival than advanced small 
cell cancer of the lung and other primary sites (hazard ratio 0.77, 95% 
conﬁdence intervals 0.71-0.85, p<0.0001). At 6 years 15% of small cell 
CUP remained alive compared to only 4% for other metastatic small 
cell patients with a known primary site almost all from the lung. 
Conclusions: Some histological subsets of CUP have a better progno-
sis than metastatic cancer at presentation. Small cell CUP has signiﬁ-
cantly better long term survival than metastatic small cell cancer of 
known primary site predominantly from the lung which suggests a need 
for genetic proﬁling and more speciﬁc treatment strategies. 
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Background: With increase of peripherally located lung cancers, clini-
cal need for percutaneous needle biopsy become high but could cause 
chest wall inoculation of cancer cells. We evaluated the expression of 
melanoma antigen gene(MAGE) A1-6 common primers from broncho-
scopic washing ﬂuid whether it could replace needle biopsy.
Materials and Methods: Twenty-nine patients with bronchoscopi-
cally invisible peripheral lung nodules were studied. Tumor locations 
were categorized by 5.8 mm ﬁberoptic bronchoscopy(Olympus, Tokyo, 
Japan). Bronchoscopic washing specimens were collected by instilla-
tion of 20ml normal saline to the tumor bearing segment and retrieved. 
Samples were divided, one for MAGE RT-PCR and the other for con-
ventional cytology. After surgery, 19 patients were diagnosed as lung 
cancer(11 squamous cell carcinoma and 8 adenocarcinoma) and 10 
were benign lung diseases. For MAGE specimens, RNA preservation 
solutions were added immediately and blindly sent to the laboratory. 
RNA extraction was performed using mRNA extraction kit and MAGE 
and GAPD were ampliﬁed using MAGE A1-6 common primers and 
sequence speciﬁc primer. We evaluated the positive rates according to 
the cell types and T stages, and compared the results with conventional 
cytology ﬁndings.
Results: From bronchial washes, positive rates of MAGE and cytol-
ogy tests showed 63.2 and 21.4% in cancer group and 10.0 and 0% in 
benign diseases group. According to cell types, positive rates of MAGE 
and cytology test were 63.6 and 28.6 % in squamous cell carcinoma, 
62.5 and 14.3 % in adenocarcinoma. According to T stages, positive 
rates of MAGE and cytology test were 71.4 and 20.0 % in T1 stage 
(N=7), 44.4 and 16.7 % in T2 stage (N=9), 100 and 33.3 % in T4 stage 
(N=3). For 11 patients with tumor size smaller than 3cm, positive rate 
of MAGE and cytology were 54.5% and 9.1%. 
Conclusions: Compared with conventional cytology test, MAGE 
A1-6 RT-PCR showed high detection rates in the bronchial washes of 
peripheral lung cancer patients. This method is simple and robust, thus 
it could be effectively utilized as a peripheral lung cancer detection tool 
in the clinical laboratory.
